Lack of in vitro ceramide formation in the PNS of trembler mice

Pathways of incorporation of fatty acid into glycerolipids of the murine peripheral nervous system in vivo: alterations in the dysmyelinating mutant trembler mouse

In vivo glycerolipid metabolism was studied in sciatic nerves of normal and Trembler mice. The results showed that two kinetically independent pathways were implicated in the labeling of diacylglycerophospholipids from [3H]palmitate: the Kennedy pathway and a 'direct acylation' pathway. In normal nerves, 45% of the glycerophospholipids were labeled, with a rate constant k3 = 3.9 x 10(-3) min-1, from phosphatidic acid and diacylglycerol intermediates, themselves formed with a rate constant of k1 = 0.24 min-1 from a free 3H-fatty acid pool, FFA1, that represents 45% of the total injected label. The remaining 55% of the glycerophospholipids were labeled from a kinetically distinct free 3H-fatty acid pool, FFA2, with a rate constant of k4 = 9.8 x 10(-2) min-1, via a process that does not implicate a detectably labeled metabolic intermediate ('direct acylation'). Glycerophospholipid labeling via the Kennedy pathway in the Trembler mouse sciatic nerves was reduced to 75% of the normal level, while labeling via the 'direct acylation' pathway was increased 1.4-fold. The values of the rate constants for free 3H-fatty acid utilisation (k1 and k4) were both increased about 2.5-fold, while that of glycerophospholipid formation from diacylglycerol (k3) was close to normal.

Cerebroside formation in the peripheral nervous system of normal and Trembler mice

The formation of cerebrosides by the galactosylation of ceramides was investigated in a microsomal fraction prepared from sciatic nerves of normal and Trembler mice. In the control, cerebroside synthesis is observed in the presence of uridine-diphosphate-galactose both from endogenously synthesized [1-14C]stearoyl-sphingosine (C18-ceramide), and from [1-14C]lignoceroyl-sphingosine (C24-ceramide). Cerebroside formation is also demonstrated by studying the galactosylation of exogenous ceramides with UDP[1-14C]-galactose. In the mutant, only trace amounts of labeled cerebrosides are formed from labeled stearoyl-sphingosine, whereas with lignoceroyl-sphingosine, no cerebroside synthesis is detected under conditions allowing their formation in the control. However, a higher rate of synthesis of short acyl chain-glucosyl ceramides is observed in the Trembler samples.

Peripheral nerve sphingomyelin and cerebroside are both formed via two metabolically and kinetically distinct pathways in vivo

We have studied the labeling kinetics of peripheral nerve sphingolipids in vivo. The kinetic analysis of the labeling profiles observed for the various sphingolipids demonstrated that 90% of cerebrosides, but only 30% of sphingomyelin, were synthesized via a de novo synthesized ceramide intermediate following the injection of 1-4 pmol [3H]palmitate into mouse sciatic nerves. The remaining sphingolipid labeling (30% of the total) was due to direct acylation events, using free fatty acids originating from a pool different from those implicated in the de novo ceramide pathway. Direct acylation events ceased within 1 h following substrate administration, while labeling via the ceramide pathway continued through 5 h. The results provide the first in vivo demonstration that the formation of cerebrosides and sphingomyelin in peripheral nerves in situ can be simultaneously assured via two metabolically and kinetically distinct pathways that employ different fatty acid pools.